caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1619060498

Roy HerbstM.D., PHD

PRACTICEMDACCSee all providers at this practice →
Medical OncologyHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
87.4
Quality
77.4
Cost
74.3
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.52%
Group
REFERRAL NETWORK

Where Roy Herbst's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
YALE NEW HAVEN HOSPITAL2247
UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER1757
Marianne Davies
Nurse Practitioner · New Haven, CT
12119
MILLER, CINDY1128
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$587K
Payment records
125
By payment type
Honoraria$400K
Consulting Fee$117K
Travel and Lodging$58K
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$9K
Food and Beverage$3K
PRESCRIBING · PART D · 2024
No data available for this provider in 2024.